Firm type · Focus area

Drug Discovery Corporate Venture Arms

The RaiseHunt database lists 245 Drug Discovery corporate venture arms: 242 of them list a portfolio, 1,617 known investments between them and 660 people at those firms have a profile here. That is the overlap between 5,455 corporate venture arms and 1,313 Drug Discovery investment firms. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in Shanghai, Cambridge and New York.

Part of corporate venture arms and Drug Discovery investment firms.

Strongest in Shanghai, Cambridge and New York

Backing rounds at Seed and Series A

245
Investment firms
242
With a known portfolio
1,617
Known investments
660
People with a profile

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

245 Drug Discovery corporate venture arms

Showing 181-200

Tokyo, Japan
Corporate VC
Healthcare
View fund
Sydney, Australia
Corporate VC
ConsumerHealthcare
View fund
Wuhan, China
Corporate VC
Healthcare
View fund
Kuala Lumpur, Malaysia
Corporate VC
Healthcare
View fund
United States
Corporate VC
AIHealthcare
View fund
Corporate VC
Healthcare
View fund
Riga, Latvia
Corporate VC
AIHealthcare
View fund
Denmark
Corporate VC
AIHealthcare
View fund
Shanghai, China
Corporate VC
Healthcare
View fund
Gaithersburg, United States
Corporate VC
Healthcare
View fund
Chuo-ku, Osaka, Japan
Corporate VC
ConsumerHealthcare
View fund
Villiers-sur-Marne, France
Corporate VC
Healthcare
View fund
Boston, United States
Corporate VC
Healthcare
View fund
Shanghai, China
Corporate VC
Healthcare
View fund
Menlo Park, United States
Corporate VC
Healthcare
View fund
Cambridge, United States
Corporate VC
Healthcare
View fund
San Francisco, United States
Corporate VC
Healthcare
View fund
Cambridge, United States
Corporate VC
Healthcare
View fund
Hoersholm, Denmark
Corporate VC
Healthcare
View fund
Dublin, Ireland
Corporate VC
Healthcare
View fund

Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal